Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Lomiko Metals, Inc. (LMRMF) Starts Presentation at 2015 Marcum MicroCap Conference

Lomiko Metals is involved in the acquisition, exploration and development of mineral resource properties in Canada, but primarily explores for graphite deposits. Its principal properties include the Vines Lake property located in British Columbia; and the Quatre Milles West and Quatre Milles East properties located in Quebec. Originally incorporated in 1987, the company’s headquarters are in Surrey, Canada. For more information, visit the company’s website at www.lomiko.com

Posted in Marcum MicroCap | Leave a comment

Milestone Scientific, Inc. (MLSS) Starts Presentation at 2015 Marcum MicroCap Conference

Milestone Scientific delivers technology-based solutions for the medical and dental markets in the United States, Canada, Asia, Africa, South America and Europe. Company products include STA Single Tooth Anesthesia Instrument, a computer-controlled local anesthesia delivery instrument that incorporates the pressure feedback elements of its patented CompuFlo technology CompuDent, which is a computer-controlled local anesthetic delivery instrument that provides painless injections for routine dental treatments. For more information, visit the company’s website at www.milesci.com

Posted in Marcum MicroCap | Leave a comment

Anavex Life Sciences Corp. (AVXL) Starts Presentation at 2015 Marcum MicroCap Conference

Anavex Life Sciences is dedicated to the development of novel drug candidates to treat central nervous system (CNS) diseases, pain and various types of cancer. The company’s lead drug candidates, ANAVEX 2-73 and ANAVEX PLUS, are currently being evaluated in a phase 2a clinical trial for Alzheimer’s disease. ANAVEX 2-73 has successfully completed a phase 1 study with a clean data profile. Preclinical studies demonstrate its potential to halt and/or reverse the course of Alzheimer’s disease. The drug combination, ANAVEX PLUS, produced up to 80% greater reversal of memory loss in Alzheimer’s disease models versus when the drugs were used individually. For more information, visit the company’s website at www.anavex.com

Posted in Marcum MicroCap | Leave a comment

True Drinks Holdings, Inc. (TRUU) Starts Presentation at 2015 Marcum MicroCap Conference

True Drinks Holdings is a healthy beverage provider with licensing agreements with Disney and Marvel for use of their characters on its proprietary, patented bottles. The company is the maker of AquaBall, a naturally flavored, vitamin-enhanced, zero-calorie, dye-free and sugar-free alternative to juice and soda that is currently available in four flavors: orange, grape, fruit punch and berry. The company’s target consumers — kids, young adults and their guardians – are particularly attracted to the product because of the entertainment and media characters on the bottle but continue to consume the beverage because of its health benefits and great taste. For more information, visit the company’s website at www.truedrinks.com

Posted in Marcum MicroCap | Leave a comment

Sanomedics, Inc. (SIMH) Starts Presentation at 2015 Marcum MicroCap Conference

Sanomedics is an international medical technology company focused on developing, manufacturing and acquiring technology, products and services through its subsidiary, Thermomedics, which is dedicated to engineering, marketing and selling the Caregiver TouchFree Infrared thermometer. The thermometer is FDA-cleared in the U.S. for clinical use and provides an accurate, expedited temperature reading without direct contact between the patient and medical professional. Sanomedics has established a wide distribution network with several leading healthcare supply chain providers to increase adoption of the Caregiver device within the medical community worldwide. For more information, visit the company’s website at www.sanomedics.com

Posted in Marcum MicroCap | Leave a comment

Avant Diagnostics (AVDX) Starts Presentation at 2015 Marcum MicroCap Conference

Avant Diagnostics is a diagnostic company mainly focused on the commercialization of OvaDx, a proprietary microarray-based diagnostic test for the early detection of ovarian cancer. Pre-clinical research studies with OvaDx indicate high sensitivity and specificity for all types and stages of ovarian cancer. Upon FDA 510K approval, Avant Diagnostics intends to sell or license OvaDx as a diagnostic test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. Avant intends to utilize its public company stage to expand its portfolio of diagnostic tests in the future. For more information, visit the company’s website at www.avantdiagnostics.com

Posted in Marcum MicroCap | Leave a comment

VirtualScopics, Inc. (VSCP) Starts Presentation at 2015 Marcum MicroCap Conference

VirtualScopics provides clinical trial imaging solutions that are meant to accelerate drug and medical device development. For risk-averse, time-constrained clinical trial study teams, medical directors and imaging scientists who require quality imaging data delivered on-time, within budget, and on a consistent basis, VirtualScopics’ clinical trial imaging solutions are inspired choices. Because of the scientific and operational flexibility and responsiveness available, VirtualScopics’ clinical trial imaging solutions deliver special performance advantages compared to other image service providers that offer common, every day clinical trial imaging services. For more information, visit the company’s website at www.virtualscopics.com.

Posted in Marcum MicroCap | Leave a comment

Inventergy Global, Inc. (INVT) Starts Presentation at 2015 Marcum MicroCap Conference

Inventergy Global is an intellectual property (IP) investment and licensing company that identifies, acquires and licenses the patented technologies of technology companies. INVT offers a professional corporate licensing model for IP value creation that provides short term returns and long-term licensing revenue. The company acquires portfolios in the telecom sector, primarily in IP multimedia subsystems, and VoIP and mobile broadband communications segments. For more information, visit the company’s website at www.inventergy.com

Posted in Marcum MicroCap | Leave a comment

Innovus Pharmaceuticals, Inc. (INNV) Starts Presentation at 2015 Marcum MicroCap Conference

Innovus Pharmaceuticals is an emerging leader in OTC consumer products for men’s and women’s health and vitality. The company generates revenues from its lead products Zestra (R) for female arousal, and EjectDelay(TM) for premature ejaculation, and has a total of five marketed products in this space, including Sensum+(TM) (for sales outside the U.S. only), Zestra Glide(R)and Vesele(R) for increasing blood flow.  The company is based in San Diego, California.  For more information, visit the company’s website at www.innovuspharma.com

Posted in Marcum MicroCap | Leave a comment

DARA BioSciences, Inc. (DARA) Starts Presentation at 2015 Marcum MicroCap Conference

DARA BioSciences is an oncology supportive care pharmaceutical company dedicated to providing health care professionals a portfolio of medicines to help cancer patients stick to their therapy and manage side effects arising from their cancer treatment. DARA holds exclusive U.S. marketing rights to the Soltamox(tamoxifen citrate) oral solution, Gelclair oral rinse gel, and Oravig(miconazole). For more information, visit the company’s website at www.darabiosciences.com

Posted in Marcum MicroCap | Leave a comment